Novo Nordisk Still Sees Potential for GLP-1 Drugs in Alzheimers...

compartilhou um link

2025-12-04 10:00:02

Novo Nordisk Still Sees Potential for GLP-1 Drugs in Alzheimers Despite Major Trial Setbacks

By Blessing NwekeNovo Nordisk says it remains optimistic that GLP-1 drugs could play a role in treating Alzheimers disease, even after two highly anticipated trials found no evidence that an older

0 Comentários 0 Compartilhamentos 25 Visualizações